How would you treat active rheumatoid arthritis in a patient in complete response on loralatinib for stage IV ALK positive NSCLC?
1 Answer
Mednet MemberInvited Expert
Rheumatology · Ohio State University
Answered on
I would do my best to minimize immunosuppression. I would use IL-6 or Abatacept and possibly rituximab. Have done all to minimize DMARDs and have had success with all 3.
Join for free or sign in to see the full answer